strain
human
coronavirus
hcov
caus
onethird
common
cold
hospitalacquir
upper
respiratori
tract
hcov
infect
report
prematur
newborn
evalu
possibl
sourc
infect
viru
surviv
studi
aqueou
suspens
absorpt
nonabsorpt
surfac
repres
hospit
environ
viru
suscept
chemic
disinfect
standard
product
also
character
viru
surviv
salin
solut
long
six
day
less
cultur
medium
without
ad
cell
dri
infect
still
detect
h
variou
surfac
aluminum
steril
latex
surgic
glove
steril
spong
surviv
h
less
variou
chemic
disinfect
test
proviodin
reduc
viru
infecti
titr
least
studi
suggest
surfac
suspens
consid
possibl
sourc
contamin
may
lead
hospitalacquir
infect
hcov
appropri
disinfect
coronavirus
envelop
rna
virus
coronavirida
viru
famili
human
coronavirus
hcov
two
known
serogroup
design
respons
onethird
common
cold
may
also
involv
seriou
diseas
exampl
previous
report
hospitalacquir
upper
respiratori
tract
infect
prematur
newborn
apnoea
bradycardia
incid
hospitalacquir
hcov
infect
estim
prospect
evalu
hospit
prematur
newborn
gestat
age
week
moreov
prospect
studi
elderli
peopl
attend
day
care
centr
coronaviru
found
common
caus
hospitalacquir
lower
respiratori
tract
infect
prevent
hospitalacquir
infect
base
knowledg
mode
transmiss
rout
entri
hcov
appear
nasal
mucosa
sinc
common
cold
produc
intranas
inocul
healthi
volunt
infect
via
conjunctiv
mucosa
describ
respiratori
syncyti
viru
rsv
demonstr
hcov
horizont
transmiss
via
small
particl
aerosol
theoret
possibl
airborn
previous
shown
surviv
long
h
control
temperatur
humid
condit
hand
contamin
environment
surfac
also
theoret
possibl
analog
rsv
rhinovirus
howev
surviv
hcov
surfac
yet
studi
current
studi
report
compar
surviv
suspens
variou
environment
surfac
commonli
found
hospit
report
suscept
common
disinfect
human
embryon
lung
cell
line
human
rectal
tumour
cell
line
well
viral
strain
origin
obtain
american
type
cultur
collect
atcc
rockvil
md
usa
cell
grown
vv
co
earl
minim
essenti
medium
hank
solut
vv
supplement
wv
sodium
bicarbon
gentamicin
canadian
life
technolog
burlington
ontario
canada
foetal
bovin
serum
fb
vv
vv
virus
clone
twice
grown
cell
describ
previous
third
passag
titr
tissu
cultur
infect
dose
w
tcid
ml
fourth
passag
titr
tcid
ml
laboratori
stock
kept
use
experi
virus
describ
dilut
three
differ
media
dulbecco
phosphat
buffer
salin
pb
cultur
medium
vv
fb
describ
cultur
medium
suscept
cell
per
ml
ad
mimic
expect
composit
sputum
could
use
directli
would
come
sick
donor
might
contain
pathogen
would
interfer
current
studi
viru
suspens
store
plastic
microtub
cryotub
nunc
interm
denmark
left
laboratori
room
temperatur
expos
daylight
differ
time
sampl
collect
triplic
store
analys
infecti
viral
titr
describ
three
differ
surfac
test
aluminium
alcan
canada
steril
cotton
gauz
spong
johnson
johnson
canada
steril
latex
surgic
glove
smith
nephew
massillon
ohio
usa
viru
surviv
test
accord
modif
previous
publish
protocol
piec
aluminum
diamet
cm
wash
tap
water
disinfect
vv
ethanol
min
heat
disinfect
steril
spong
glove
cut
experi
aliquot
viru
suspens
describ
drop
surfac
allow
dri
laminar
flow
hood
min
piec
dri
materi
place
steril
petri
dish
differ
time
piec
materi
place
plastic
microtub
cryotub
nunc
contain
pb
incub
sonic
water
bath
branson
shelton
usa
eluat
store
could
analys
infecti
viral
titr
describ
experi
three
piec
materi
test
neg
control
pb
dri
surfac
temperatur
kept
humid
experi
white
box
stamford
connecticut
usa
variou
common
disinfect
agent
evalu
vv
ethanol
proviodin
deterg
contain
free
iodin
rougier
chambl
canada
freshli
prepar
vv
domest
bleach
morenc
canada
soap
synergel
choisi
louisevil
canada
ten
microlitr
aliquot
viru
suspens
describ
mix
serial
dilut
disinfect
contact
time
min
cultur
medium
ad
mixtur
store
analys
infecti
viral
titr
describ
addit
monitor
cytotox
effect
could
mask
detect
infecti
viru
effect
disinfect
abil
viru
infect
cell
assay
preincub
dilut
disinfect
cell
monolay
min
follow
wash
pb
fix
dilut
viru
ad
infecti
viru
titr
assay
describ
except
well
use
suscept
cell
confluenc
inocul
serial
dilut
sampl
linbro
plate
flow
mclean
virginia
usa
five
day
incub
humidifi
chamber
vv
co
cell
wash
pb
fix
vv
hydrogen
peroxid
sigma
st
loui
mo
usa
methanol
min
wash
pb
incub
h
vv
co
virusspecif
monoclon
antibodi
produc
laboratori
standard
hybridoma
technolog
cell
wash
three
time
pb
horseradish
peroxidaseconjug
antimous
immunoglobulin
cappel
durham
north
carolina
usa
ad
incub
h
without
co
bound
antibodi
detect
incub
wv
diaminobenzidinetetrahydrochlorid
biorad
richmond
california
usa
vv
hydrogen
peroxid
sigma
pb
colour
reaction
stop
deioniz
water
infecti
viru
titr
calcul
karber
method
use
four
well
per
sampl
dilut
neg
posit
control
consist
noninfect
cell
cell
infect
estim
multipl
infect
moi
respect
evalu
surviv
human
coronaviru
hcov
infect
variou
incub
may
reflect
clinic
relev
situat
result
experi
express
percentag
infect
recov
variou
treatment
compar
start
infecti
titr
figur
show
viru
surviv
aqueou
suspens
could
surviv
least
six
day
experiment
condit
halflif
approxim
five
day
pb
two
three
day
two
media
figur
show
surviv
dri
time
zero
repres
time
dri
rapid
loss
viru
infect
remark
two
virus
surfac
infect
still
detect
h
figur
describ
infect
hcov
inactiv
chemic
disinfect
suspens
dilut
disinfect
interfer
biolog
viral
titrat
assay
tabl
reduct
infect
two
virus
observ
chemic
disinfect
proviodin
howev
disinfect
requir
ten
time
concentr
proviodin
solut
reduct
viru
infect
could
measur
reduct
infecti
viru
titr
treatment
chemic
agent
ethanol
soap
bleach
cytotox
tabl
interf
biolog
viral
titrat
assay
dilut
disinfect
might
expect
effect
elimin
infecti
virus
technic
limit
may
mean
underestim
disinfect
efficaci
product
viral
infect
respiratori
tract
patient
shed
larg
amount
viru
nasotrach
secret
contamin
environ
respiratori
virus
rsv
rhinoviru
parainfluenza
viru
shown
surviv
extend
period
suspens
surfac
contamin
environment
surfac
consid
repres
signific
vector
hospitalacquir
viral
infect
occur
frequent
paediatr
unit
therefor
appropri
disinfect
surfac
import
control
prevent
crossinfect
although
hcov
also
found
involv
hospitalacquir
infect
surviv
environ
yet
test
condit
similar
respiratori
virus
therefor
test
surviv
two
known
hcov
strain
suspens
surfac
use
laboratori
condit
design
reproduc
found
hospit
environ
well
possibl
tabl
shown
one
hundr
percent
infect
repres
infecti
titr
viru
incub
pb
chemic
disinfect
assay
current
studi
demonstr
surviv
pb
suspens
hcov
six
day
differ
two
hcov
strain
cultur
medium
suscept
cell
test
mimic
human
respiratori
secret
without
possibl
interfer
contamin
pathogen
might
found
sputum
laboratori
condit
use
previou
studi
goal
surviv
appar
shorter
two
virus
incub
cultur
medium
without
suscept
cell
compar
pb
presum
ph
stabil
pb
could
explain
observ
infect
previous
shown
optim
ph
decreas
rapidli
ph
viru
found
stabl
cycl
freez
thaw
also
test
hcov
surviv
dri
accord
publish
protocol
modifi
order
test
differ
environment
surfac
found
hospit
particular
test
porou
nonpor
surfac
sinc
differ
surviv
accord
type
surfac
describ
respiratori
virus
expect
viru
surviv
dri
shorter
suspens
without
differ
surfac
viru
strain
variat
accord
temperatur
humid
test
studi
indic
hcov
abl
surviv
sever
day
suspens
hour
dri
result
consist
possibl
persontoperson
viru
transmiss
via
hand
contamin
surfac
describ
respiratori
virus
exampl
rsv
recover
counter
top
h
rubber
glove
h
human
rhinoviru
type
could
surviv
h
incub
suspens
tryptos
phosphat
broth
shorter
time
bovin
mucin
nasal
secret
also
parainfluenza
viru
type
could
recov
nonabsorpt
surfac
long
h
contamin
site
remain
moist
h
dri
absorpt
surfac
surviv
vari
h
depend
materi
test
skin
infect
parainfluenza
viru
decreas
rapidli
remain
detect
h
hand
rsv
could
recov
skin
surfac
min
rhinovirus
could
surviv
h
test
surviv
hcov
human
skin
ethic
concern
regard
risk
acut
respiratori
tract
infect
possibl
neurolog
damag
prevent
reduc
possibl
persontoperson
transmiss
virus
via
surfac
disinfect
import
therefor
test
disinfect
activ
hcov
four
class
disinfect
wide
use
hospit
observ
sensit
proviodin
sinc
neutral
lower
concentr
chemic
disinfect
virucid
activ
domest
bleach
soap
could
establish
inher
cytotox
despit
dilut
virusdisinfect
mixtur
pb
medium
dilut
reduc
initi
viru
titr
tcid
ml
fold
reduct
infecti
viral
titr
recommend
german
dvv
french
afnor
guidelin
assess
efficaci
disinfect
imposs
observ
rsv
krilov
hark
demonstr
fold
reduct
providoneiodin
dilut
use
ethanol
allow
detect
virucid
activ
sinc
fix
virussuscept
cell
immunoperoxidas
assay
presenc
lipid
make
envelop
virus
coronavirus
sensit
disinfect
damag
lipid
solvent
thu
use
soap
ethanol
effect
sinc
alcohol
deterg
destabil
lipid
bilay
envelop
virus
offici
guidelin
prevent
hcov
transmiss
despit
report
hospitalacquir
coronaviru
infect
possibl
prolong
surviv
virus
suspens
efficaci
common
disinfect
support
use
measur
develop
prevent
rsv
respiratori
viru
crossinfect
handwash
disinfect
surfac
staff
educ
